EligibleTrials

NI-1801 in combination with anti-PD1 (Pembrolizumab): clinical trials recruiting now

Fewer than 3 recruiting trials found.

1
Recruiting trials
8
Conditions studied
0
US states with sites
2
Countries

Phase breakdown

Phase 1 1

Conditions being studied

ConditionTrials
Breast cancer1
Endometrioid Ovarian Cancer1
Epithelial Ovarian Cancer1
Lung cancer1
Non-squamous Non-small-cell Lung Cancer1
Pancreatic Adenocarcinoma (ductal Adenocarcinoma)1
Pancreatic cancer1
Triple Negative Breast Cancer1

Recruiting trials involving NI-1801 in combination with anti-PD1 (Pembrolizumab)

Common questions

How many recruiting trials involve NI-1801 in combination with anti-PD1 (Pembrolizumab)?

1 recruiting trial across 8 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.